ArticleJACC. Case reports2026
Posterior MAD, Fibrosis, and Bileaflet MVP: A High-Risk Imaging Phenotype for Sudden Cardiac Arrest.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mitral Annular Disjunction and Fibrosis in Bileaflet MVP: High-Risk Phenotype for Sudden Cardiac Arrest.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMitral annular disjunction (MAD) is an under-recognized abnormality frequently associated with mitral valve prolapse (MVP) and linked to malignant arrhythmias and sudden cardiac death. CASE SUMMARY: A 42-year-old woman with bileaflet MVP presented with sudden cardiac arrest from ventricular fibrillation. Prior electrocardiography revealed inferior T-wave inversions, whereas transthoracic echocardiography identified posterior MAD. Cardiac magnetic resonance demonstrated focal late gadolinium enhancement, consistent with myocardial fibrosis. Together, these multimodality findings defined a malignant arrhythmogenic substrate and reinforced the indication for implantable cardioverter-defibrillator placement. DISCUSSION: This case highlights the malignant potential of the MVP-MAD phenotype and the challenge of early detection. Risk stratification should integrate clinical history, arrhythmic burden assessment, and advanced imaging to collectively delineate high-risk features. Longitudinal surveillance remains essential, as the phenotype may evolve and culminate in sudden cardiac arrest. TAKE-HOME MESSAGE: In MVP, recognition of MAD and cardiac magnetic resonance-detected fibrosis is essential, as malignant phenotypes may go undetected until presenting with sudden cardiac arrest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.